Logo image of MWX.CA

MINEWORX TECHNOLOGIES LTD (MWX.CA) Stock Fundamental Analysis

TSX-V:MWX - TSX Venture Exchange - CA6034653031 - Common Stock - Currency: CAD

0.08  0 (0%)

Fundamental Rating

1

Taking everything into account, MWX scores 1 out of 10 in our fundamental rating. MWX was compared to 811 industry peers in the Metals & Mining industry. Both the profitability and financial health of MWX have multiple concerns. MWX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

MWX had negative earnings in the past year.
In the past year MWX has reported a negative cash flow from operations.
MWX.CA Yearly Net Income VS EBIT VS OCF VS FCFMWX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 2M -2M 4M -4M 6M -6M

1.2 Ratios

The profitability ratios for MWX are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MWX.CA Yearly ROA, ROE, ROICMWX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 50 -50

1.3 Margins

MWX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MWX.CA Yearly Profit, Operating, Gross MarginsMWX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021

More info and screens

3

2. Health

2.1 Basic Checks

The number of shares outstanding for MWX has been increased compared to 1 year ago.
Compared to 1 year ago, MWX has a worse debt to assets ratio.
MWX.CA Yearly Shares OutstandingMWX.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M
MWX.CA Yearly Total Debt VS Total AssetsMWX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2M 4M 6M 8M 10M

2.2 Solvency

MWX has an Altman-Z score of 0.79. This is a bad value and indicates that MWX is not financially healthy and even has some risk of bankruptcy.
MWX has a Altman-Z score of 0.79. This is comparable to the rest of the industry: MWX outperforms 45.29% of its industry peers.
A Debt/Equity ratio of 0.21 indicates that MWX is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.21, MWX is doing worse than 74.64% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Altman-Z 0.79
ROIC/WACCN/A
WACCN/A
MWX.CA Yearly LT Debt VS Equity VS FCFMWX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 5M -5M 10M

2.3 Liquidity

MWX has a Current Ratio of 6.05. This indicates that MWX is financially healthy and has no problem in meeting its short term obligations.
MWX has a Current ratio of 6.05. This is in the better half of the industry: MWX outperforms 72.54% of its industry peers.
MWX has a Quick Ratio of 6.05. This indicates that MWX is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of MWX (6.05) is better than 72.87% of its industry peers.
Industry RankSector Rank
Current Ratio 6.05
Quick Ratio 6.05
MWX.CA Yearly Current Assets VS Current LiabilitesMWX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 1M 2M 3M 4M

More info and screens

0

3. Growth

3.1 Past

MWX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 60.54%, which is quite impressive.
EPS 1Y (TTM)60.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.15%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MWX. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MWX.CA Price Earnings VS Forward Price EarningsMWX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MWX.CA Per share dataMWX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 -0.01 0.02 0.03 0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MWX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MINEWORX TECHNOLOGIES LTD

TSX-V:MWX (1/19/2023, 7:00:00 PM)

0.08

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.17%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap27.77M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.94
P/tB 2.04
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.04
TBVpS0.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 355.09%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.05
Quick Ratio 6.05
Altman-Z 0.79
F-Score1
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)121.1%
Cap/Depr(5y)79.05%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)60.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.15%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-34.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-310.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-170.04%
OCF growth 3YN/A
OCF growth 5YN/A